Therefore, our study results showing a reduced warfarin daily dose and lower odd of TTR>60% in NAFLD/NASH patients may relate to the anticoagulation abnormalities caused by hepatic dysfunction. Here, TTR is linked to metabolic dysfunction-associated steatotic liver disease.